We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.15B
AUM Growth
-$3.94B
Cap. Flow
-$4.44B
Cap. Flow %
-106.94%
Top 10 Hldgs %
33.3%
Holding
6,378
New
470
Increased
1,548
Reduced
3,513
Closed
532

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$61.6M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$32.2M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$21.8M
4
USO icon
United States Oil Fund
USO
+$12.8M
5
XLB icon
State Street Materials Select Sector SPDR ETF
XLB
+$11.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$263M
2
AAPL icon
Apple
AAPL
+$226M
3
AMZN icon
Amazon
AMZN
+$127M
4
NVDA icon
NVIDIA
NVDA
+$115M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$80.9M

Sector Composition

Rank Sector Weight
1 Technology 26.16%
2 Consumer Discretionary 9.21%
3 Communication Services 8.49%
4 Financials 7.96%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LONA
3476
LeonaBio Inc
LONA
$74.8M
$12.5K ﹤0.01%
456
+425
+1,371% +$13.5K
ZSTK
3477
ZeroStack Corp
ZSTK
$22.4M
$12.5K ﹤0.01%
139
-24
-15% -$1.19K
MYI icon
3478
BlackRock MuniYield Quality Fund III
MYI
$720M
$12.5K ﹤0.01%
+1,034
New +$11.8K
MAIA icon
3479
MAIA Biotechnology
MAIA
$85.2M
$12.5K ﹤0.01%
5,665
+2,071
+58% +$3.11K
RZLT icon
3480
Rezolute
RZLT
$443M
$12.5K ﹤0.01%
4,886
-6,449
-57% -$9.18K
CTO
3481
CTO Realty Growth
CTO
$825M
$12.4K ﹤0.01%
734
-9,736
-93% -$164K
TARS icon
3482
Tarsus Pharmaceuticals
TARS
$3.04B
$12.4K ﹤0.01%
342
-4,218
-93% -$124K
ALTO icon
3483
Alto Ingredients
ALTO
$324M
$12.4K ﹤0.01%
5,702
-18,253
-76% -$38.5K
PKE icon
3484
Park Aerospace
PKE
$831M
$12.4K ﹤0.01%
744
-1,414
-66% -$21K
IEV icon
3485
iShares Europe ETF
IEV
$1.7B
$12.4K ﹤0.01%
222
-343
-61% -$18.3K
DGII icon
3486
Digi International
DGII
$3.23B
$12.4K ﹤0.01%
387
-11,215
-97% -$313K
TCMD icon
3487
Tactile Systems Technology
TCMD
$548M
$12.3K ﹤0.01%
760
-11,290
-94% -$171K
ATER icon
3488
Aterian
ATER
$5.44M
$12.3K ﹤0.01%
4,474
+3,073
+219% +$13.1K
GPCR icon
3489
Structure Therapeutics
GPCR
$3.87B
$12.3K ﹤0.01%
288
-775
-73% -$32.7K
UONEK icon
3490
Urban One Class D
UONEK
$23.4M
$12.3K ﹤0.01%
604
+304
+101% +$9.28K
NPKI
3491
NPK International
NPKI
$1.21B
$12.3K ﹤0.01%
1,702
-18,596
-92% -$121K
MLNK
3492
DELISTED
MeridianLink
MLNK
$12.3K ﹤0.01%
657
-6,551
-91% -$133K
ENVB icon
3493
Enveric Biosciences
ENVB
$6.16M
$12.3K ﹤0.01%
68
-2
-3% -$385
STLN
3494
Starling Oncology, Inc. Common Stock
STLN
$657M
$12.2K ﹤0.01%
7,752
-4,294
-36% -$8.16K
IDCC icon
3495
InterDigital
IDCC
$8.87B
$12.2K ﹤0.01%
115
-11,207
-99% -$1.18M
RXT icon
3496
Rackspace Technology
RXT
$1.07B
$12.2K ﹤0.01%
7,746
-13,422
-63% -$24.1K
WLKP icon
3497
Westlake Chemical Partners
WLKP
$765M
$12.2K ﹤0.01%
551
-686
-55% -$15.4K
ATYR
3498
aTyr Pharma
ATYR
$54.8M
$12.2K ﹤0.01%
+6,267
New +$10.9K
CDMO
3499
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$12.2K ﹤0.01%
1,824
-2,596
-59% -$17.9K
SANA icon
3500
Sana Biotechnology
SANA
$1.06B
$12.2K ﹤0.01%
1,222
-32,885
-96% -$246K
138 139
140
141 142

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2024 Portfolio in Review

As of Q1 2024, Tower Research Capital (TRC) held 6,378 positions worth $4.15B, down 49% from $8.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.44B in Q1 2024, closing 532 positions and reducing 3,513 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $49.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares S&P Small-Cap 600 Growth ETF worth $3.77M.

  • Tower Research Capital (TRC)'s largest Q1 2024 buy was iShares S&P Small-Cap 600 Growth ETF: 28,851 shares worth $3.77M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q1 2024, an estimated $61.6M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2024 reduction was Microsoft, cutting an estimated $263M.
  • Tower Research Capital (TRC) fully exited State Street Financial Select Sector SPDR ETF in Q1 2024, selling an estimated $49.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 33% of its $4.15B portfolio in Q1 2024.
  • Tower Research Capital (TRC) opened 470 new positions and closed 532 in Q1 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 49% quarter-over-quarter to $4.15B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.